Matis Louis 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Feb 26, 2018
Insider Transaction Report
Form 4
Matis Louis
SVP, Chief Development Officer
Transactions
- Award
Stock Options (Right to buy)
2018-02-20+100,000→ 100,000 totalExercise: $8.56Exp: 2028-02-20→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the option shares on January 1, 2019 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.